Email: Password:
| Forgot Password
Nav_logo

A free online accredited CPD program for healthcare professionals

What do the New Clinical Trials on COPD Mean for You?

1.00 Canadian Council On Continuing Education In Pharmacy (CCCEP) CEU(s) / / / 1.00 Ordre des pharmaciens du Québec (OPQ) CEU(s)

Program available online until: October 19, 2019



This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP)
for 1.00 CEU(s).

CCCEP File Number: 1066-2018-2581-I-P

This continuing education activity has been accredited by l'Ordre des Pharmaciens du Quebec, which will grant 1.00 CEU(s) to pharmacists who have completed it successfully.

OPQ Activity Number: 5477

New Clinical Trials on COPD

Chronic Obstructive Pulmonary Disease

The findings from recent clinical trials have important implications for the pharmacologic management of chronic obstructive pulmonary disease (COPD). Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. In Canada, COPD approximately 4% of Canadians have been diagnosed with COPD, but the actual prevalence is estimated to be much higher. This educational program will discuss recent studies involving the pharmacologic management of COPD, and current treatment recommendations.

Planning Committee

  • Gordon Dyck, MD, MCFP, BSc(Med), BA.
  • Simon Lessard, B.Pharm, MBA, CRE, CTE.
  • Hema Rajawat, BSc. Pharm, RPh.

Learning Objectives

On completion of this program, participants should be able to:

  • Describe the management of COPD as per the GOLD 2018 report and the CTS 2017 position statement
  • Describe the FLAME study and the role of dual LABA/LAMA therapy in COPD
  • Discuss the IMPACT study and the role triple combination therapy in COPD
  • Apply follow-up strategies to ensure proper long-term management of COPD patients

Find out more from our Expert: Gordon Dyck, MD, MCFP, BSc(Med), BA

  1. How is COPD differentiated from asthma?
  2. What are the roles of short-acting and long-acting bronchodilators in the management of COPD?
  3. What were the key results of the FLAME trial?
  4. What were the key findings from the IMPACT trial?
  5. What is the treatment algorithm for COPD?
Content/Programs/CaseStudy/COPD_ClinicalTrials_10314/assets/thumbnails/DyckG_LP.jpg

mdBriefCase is the practical choice to earn your CPD Credits

Icon of multiple pages

20+ therapeutic areas

100+ programs each year.

Icon of multiple pages

Quality, accredited content

Developed by leading specialists and peer-reviewed by experts at respected institutions.

Icon of multiple pages

Online convenience

Save time and money.

Join 45,000+ of your colleagues

Create your free account today